Unlocking success in the evolving pharma landscape: Insights from Norstella’s Daniel Chancellor

evolving-pharma-landscape

Norstella’s Daniel Chancellor opines on the essential big picture dynamics in today’s pharma landscape. With clinical advances benefitting patients that had been previously overlooked, pharma companies are shifting how they build their pipelines and communicate value to payers. Deciding on the right strategies relies on having access to the best data, learning the lessons from […]